Application 021216
- Type
- NDA
- Sponsor
- PARKE DAVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEURONTIN | GABAPENTIN | SOLUTION; ORAL | 250MG/5ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | be9a572d-e98a-41c1-83c5-859d9176dd1c | 2025-10-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | eaf5e41e-8ed3-404e-84e0-392bebdbc0b7 | 2025-10-03 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | da8438e1-755b-4195-baa7-464f3d9ee5bd | 2025-10-01 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 8f982b95-4e84-4e0c-a543-747bc3dd7531 | 2025-09-26 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d0510d04-460c-47d1-be72-0ee32c4ac640 | 2025-09-26 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 344d67fa-092e-4e71-b96a-25c71bfa6bb1 | 2025-09-25 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | bc1316b6-1fc4-4990-95a8-489881772876 | 2025-09-25 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 3f2ba3d6-6086-eaf2-e063-6294a90a7642 | 2025-09-19 | Warnings, Adverse reactions | GABAPENTIN |
| gabapentin | GABAPENTIN | Coupler LLC | 3eeda97d-c3cd-65cd-e063-6394a90aae8b | 2025-09-16 | Warnings, Adverse reactions | GABAPENTIN |
| gabapentin | GABAPENTIN | Zydus Lifesciences Limited | 8c0eeefc-ef5b-49f4-8411-ddbae312ed05 | 2025-09-15 | GABAPENTIN | |
| GABAPENTIN | GABAPENTIN | MARKSANS PHARMA LIMITED | 98bb408d-c402-4da6-8f9d-5de4833dedc4 | 2025-09-12 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Epic Pharma, LLC | d592d828-8df1-480d-b179-bb9260a9c824 | 2025-09-12 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 310ce005-5a24-489a-b23c-d42ab6a3bfed | 2025-09-08 | Warnings, Adverse reactions | GABAPENTIN |
| gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 3cfd04ab-e421-441f-a10e-e4dd1412974d | 2025-09-05 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | b1a9808d-31a5-4b63-afd0-d96d5a0ad7a1 | 2025-09-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 74474aa4-4859-42d2-92d8-f23f18b34e04 | 2025-08-21 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | 2cb1ad6d-d389-4564-e063-6394a90a3644 | 2025-08-19 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 137b2b9a-9d42-48d0-913f-5dc146fb689a | 2025-08-19 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | b4c7388a-19d9-4e3a-83c9-4943fb855be4 | 2025-08-18 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 9ead7825-d11b-4e00-8533-328d097b8f83 | 2025-08-16 | Warnings, Adverse reactions | GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.